Drug Approval | November 13, 2024
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
US Generics grew 5% to Rs. 467 Crores for the quarter
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Subscribe To Our Newsletter & Stay Updated
